What is Monte Rosa Therapeutics, Inc.'s gain/loss on asset sales?

Monte Rosa Therapeutics, Inc. (GLUE) reported gain/loss on asset sales of $0 in Q1 2026.

How has Monte Rosa Therapeutics, Inc.'s gain/loss on asset sales changed year-over-year?

Monte Rosa Therapeutics, Inc.'s gain/loss on asset sales decreased by 100.0% year-over-year, from $59K to $0.

What does gain/loss on asset sales mean?

Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.

Monte Rosa Therapeutics, Inc. GLUE Gain/Loss on Asset Sales

Gain/Loss on Asset Sales at other companies

Nurix Therapeutics, Inc.NRIX

-$160K—

ImmunomeIMNM

-$79K—

Cogent Biosciences, Inc.COGT

-$135K—

Other financials

Income statement

See full

Revenue$4.2M-95.0%

Operating income-$50.0M-214%

Net income-$44.5M-195%

EPS (diluted)-$0.45-179%

Balance sheet

See full

Cash & equivalents$159.9M+104%

Total debt$39.1M-6.7%

Total equity$521.9M+89.7%

Total assets$736.4M+87.3%

Cash flow

See full

Operating cash flow-$37.4M+17.9%

CapEx$1.9M+17.7%

Free cash flow-$39.2M+16.7%

Valuation

See full

Market cap$1.76B+361%

Profitability

See full

Operating margin-345.2%—

Net margin-302.6%—

FCF margin-45.8%-64.9pp

Returns & leverage

See full

Return on equity-32.6%—

Debt / equity0.1×-0.1×

Current ratio9.5×+3.9×

Where this comes from

Reported directly by Monte Rosa Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnSaleOfPropertyPlantEquipment.

The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Monte Rosa Therapeutics, Inc.'s gain/loss on asset sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Monte Rosa Therapeutics, Inc.'s gain/loss on asset sales?: Monte Rosa Therapeutics, Inc. (GLUE) reported gain/loss on asset sales of $0 in Q1 2026.
How has Monte Rosa Therapeutics, Inc.'s gain/loss on asset sales changed year-over-year?: Monte Rosa Therapeutics, Inc.'s gain/loss on asset sales decreased by 100.0% year-over-year, from $59K to $0.
What does gain/loss on asset sales mean?: Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.